BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2903577)

  • 1. Cytofluorometric identification of plasmin-sensitive factor XIIIa binding to platelets.
    Kreager JA; Devine DV; Greenberg CS
    Thromb Haemost; 1988 Aug; 60(1):88-93. PubMed ID: 2903577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific binding of blood coagulation factor XIIIa to thrombin-stimulated platelets.
    Greenberg CS; Shuman MA
    J Biol Chem; 1984 Dec; 259(23):14721-7. PubMed ID: 6150044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen interaction with platelets: the importance of carboxyterminal lysines.
    Horne MK; Merryman PK; Cullinane AM
    Thromb Res; 2005; 116(6):499-507. PubMed ID: 15894352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet factor XIII becomes active without the release of activation peptide during platelet activation.
    Muszbek L; Polgár J; Boda Z
    Thromb Haemost; 1993 Mar; 69(3):282-5. PubMed ID: 8097064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-associated factor XIII in platelet activation, adhesion, and clot stabilization.
    Devine DV; Bishop PD
    Semin Thromb Hemost; 1996; 22(5):409-13. PubMed ID: 8989824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin-independent activation of platelet factor XIII by endogenous platelet acid protease.
    Lynch GW; Pfueller SL
    Thromb Haemost; 1988 Jun; 59(3):372-7. PubMed ID: 2903573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of thrombospondin as a substrate for factor XIII transglutaminase.
    Lynch GW; Slayter HS; Miller BE; McDonagh J
    J Biol Chem; 1987 Feb; 262(4):1772-8. PubMed ID: 2879842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet heterogeneity: variation in coagulation complexes on platelet subpopulations.
    Kempton CL; Hoffman M; Roberts HR; Monroe DM
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):861-6. PubMed ID: 15653564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of plasmin-induced platelet aggregation.
    Watabe A; Ohta M; Matsuyama N; Mizuno K; el Borai N; Tanimoto T; Kawanishi T; Hayakawa T
    Res Commun Mol Pathol Pharmacol; 1997 Jun; 96(3):341-52. PubMed ID: 9261893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin.
    Baglia FA; Walsh PN
    Biochemistry; 1998 Feb; 37(8):2271-81. PubMed ID: 9485373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombospondin is a substrate for blood coagulation factor XIIIa.
    Bale MD; Mosher DF
    Biochemistry; 1986 Sep; 25(19):5667-73. PubMed ID: 2877688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A binding site expressed on the surface of activated human platelets is shared by factor X and prothrombin.
    Scandura JM; Ahmad SS; Walsh PN
    Biochemistry; 1996 Jul; 35(27):8890-902. PubMed ID: 8688425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tb(III)-ion-binding-induced conformational changes in platelet factor XIII.
    Achyuthan KE; Mary A; Greenberg CS
    Biochem J; 1989 Jan; 257(2):331-8. PubMed ID: 2564774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen Chapel Hill II: defective in reactions with thrombin, factor XIIIa and plasmin.
    Carrell N; McDonagh J
    Br J Haematol; 1982 Sep; 52(1):35-47. PubMed ID: 6126210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure of human platelets to plasmin results in the expression of irreversibly active fibrinogen receptors.
    Rabhi-Sabile S; Pidard D
    Thromb Haemost; 1995 Apr; 73(4):693-701. PubMed ID: 7495081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface.
    Dale GL; Friese P; Batar P; Hamilton SF; Reed GL; Jackson KW; Clemetson KJ; Alberio L
    Nature; 2002 Jan; 415(6868):175-9. PubMed ID: 11805836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A microtiter plate assay for factor XIII A-chain-fibrin interactions.
    Achyuthan KE; Santiago MA; Greenberg CS
    Anal Biochem; 1994 May; 219(1):43-8. PubMed ID: 8059954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation of cellular factor XIII into an active zymogen transglutaminase in thrombin-stimulated platelets.
    Muszbek L; Haramura G; Polgár J
    Thromb Haemost; 1995 Apr; 73(4):702-5. PubMed ID: 7495082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.